ORION Biotech Catalyst Calendar
Menu
Skip to company history
COMPANY HISTORY / RETAINED ORIGINAL SOURCES

What did the company say,
and what came next?

In the reviewed release recorded , ORION retains 3 historical announcement records as of for Beam Therapeutics (BEAM). Read the original sources and their publication dates below or inspect the dated catalog.

Last updated: · reviewed catalog release, not a fresh source check

  1. 1 Choose one ticker
  2. 2 Read the evidence
  3. 3 Keep a starting point

10 companies · 24 retained records · Reviewed 2026-09-26T07:20:44Z.

What did BEAM disclose about BEAM-101?

Beam Therapeutics · BEACON Phase 1/2 initial clinical data · 3 retained source records as of .

Earlier selected statement

Read the source context →

Stated timing: Second half of 2024

Source published · Original announcement. ORION first recorded .

Later selected disclosure

Read the source context →

Source published · Original announcement. ORION first recorded .

Follow-up research question

How do the abstract and later presentation differ in patient count, follow-up and safety findings?

YOUR PRIVATE STARTING POINT

Compare with what you saved.

Save a milestone to your account’s Notebook. Reopen its original snapshot here and compare with this reviewed catalog. Email subscriptions use a separate opt-in.

Sign inManage Notebook allowance
Source index · readable without the interactive view

Beam Therapeutics (BEAM)

BEACON Phase 1/2 initial clinical data

  1. 2024 milestones: BEAM-101 first clinical data

    Beam expected initial data from multiple BEACON participants in the second half of 2024.

    Stated timing: Second half of 2024

    Original announcement.

    Source published (published_at)
    Event effective (effective_at)
    UNAVAILABLE
    ORION first seen (first_seen_at)
    ORION ingested (ingested_at)
  2. ASH abstracts: first BEAM-101 clinical data

    Beam released initial BEACON findings with accepted ASH abstracts. The preliminary data used a July 2 cutoff. The release also described a patient death judged likely related to conditioning and unrelated to BEAM-101; readers should review the full safety context.

    Original announcement.

    Source published (published_at)
    Event effective (effective_at)
    ORION first seen (first_seen_at)
    ORION ingested (ingested_at)
  3. ASH announcement: updated BEACON data

    Beam announced updated BEACON data using an October 28 cutoff, including seven treated participants in the analysis. This was an additional disclosure after the November abstract, not a second initial-data promise.

    Original announcement.

    Source published (published_at)
    Event effective (effective_at)
    ORION first seen (first_seen_at)
    ORION ingested (ingested_at)

Scope

These selected company announcements preserve publication dates separately from ORION’s later recording times. Registry completion dates and follow-up research questions are separate from company announcements; this historical release does not establish current guidance or continuous monitoring.

Coverage & method → · Corrections · Catalog manifest

THE WEEKLY RESEARCH NOTE

Keep the original sources close.

Sign up for ORION’s free English research email. Company-specific monitoring is separate.

Checking email signup availability…